ADAMTS-8 inhibitors represent a specialized class of chemical compounds engineered to exert precise control over the activity of ADAMTS-8, an enzyme belonging to the ADAMTS (A Disintegrin-like And Metalloproteinase with Thrombospondin type-1 motif) family. These enzymes are integral components of the body's extracellular matrix (ECM) remodeling machinery. ADAMTS-8, in particular, plays a pivotal role in regulating essential physiological processes like cartilage development, angiogenesis, and tissue repair. By specifically targeting ADAMTS-8, inhibitors can modulate its enzymatic functions, influencing the degradation and reconstruction of ECM components.ADAMTS-8 inhibitors are at the forefront of scientific exploration due to their potential to uncover critical insights into ECM dynamics. These compounds offer a valuable tool for investigating the fundamental mechanisms of tissue maintenance and regeneration.
Their selective interference with ADAMTS-8's enzymatic activities enables researchers to dissect the enzyme's role in both normal and pathological conditions. This knowledge can inform advancements in tissue engineering and regenerative medicine, aiding the development of innovative biomaterials and strategies to enhance tissue repair. Furthermore, ADAMTS-8 inhibitors can be instrumental in elucidating the intricate interplay of ECM components and their influence on cell behavior, paving the way for a deeper understanding of tissue physiology. In conclusion, ADAMTS-8 inhibitors represent a chemically distinct class of compounds with a specific purpose: to modulate the activity of the ADAMTS-8 enzyme. While their primary application is in research, these inhibitors have the potential to unlock critical insights into ECM dynamics and tissue physiology. Their selective targeting of ADAMTS-8 may contribute to advancements in fields such as tissue engineering and biomaterial development, ultimately shaping our understanding of tissue maintenance and repair.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TAPI-1 | 171235-71-5 | sc-222337 | 1 mg | $669.00 | 15 | |
Broad-spectrum metalloproteinase inhibitor that may inhibit ADAMTS-8 by chelating the catalytic zinc ion. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
A synthetic matrix metalloproteinase (MMP) inhibitor that may have inhibitory effects on ADAMTS-8. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Another MMP inhibitor that may indirectly affect ADAMTS-8 activity by targeting related metalloproteinases. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
A broad-spectrum metalloproteinase inhibitor that can potentially inhibit ADAMTS-8 enzymatic activity. | ||||||
Prinomastat | 192329-42-3 | sc-507449 | 5 mg | $190.00 | ||
An MMP inhibitor that might indirectly influence ADAMTS-8 activity by suppressing related metalloproteinases. | ||||||
ARP 100 | 704888-90-4 | sc-203522 | 5 mg | $208.00 | 26 | |
A broad-spectrum metalloproteinase inhibitor that may affect ADAMTS-8 enzymatic function through zinc ion chelation. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
A selective inhibitor of MMP-2 and MMP-9, which may impact ADAMTS-8 indirectly by modulating the extracellular matrix. | ||||||